Lantern Pharma announces unexpected death of director Dr. Franklyn Prendergast

Lantern Pharma Inc.

Dr. Franklyn Prendergast died unexpectedly; company learned on October 17, 2023.
Prendergast had served as a director of Lantern Pharma since October 2019.
No replacement or board succession plan disclosed in the filing.

item 8.01

Lantern Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-037907

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.